Please assess the completion status of the following clinical trial:

Trial Title: Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Previously diagnosed, or newly diagnosed essential hypertension. Blood pressure must be within a minimum and maximum range prior to drug treatment.~Exclusion Criteria:~* Inability to discontinue all prior antihypertensive medications~* Heart failure~* History of stroke, myocardial infarction, or chest pain within 3 years, or an abnormal heart rhythm~* Liver or kidney disease~* Certain drugs used to treat other conditions like an enlarged prostate gland, or arthritis~* Allergy or reactions to certain medications used to treat high blood pressure~Other protocol-defined inclusion and exclusion criteria apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).